Sunesis Pharmaceuticals Inc (VIRX):企業の財務・戦略的SWOT分析

◆英語タイトル:Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH33264FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sunesis Pharmaceuticals Inc (VIRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sunesis Pharmaceuticals Inc (Sunesis), formerly Mosaic Pharmaceuticals, Inc. develops and markets cancer therapeutics for the treatment of solid and hematologic cancers. The company’s pipeline products include Vecabrutinib (SNS-062) for the treatment of chronic lymphocytic leukemia (CLL) and other B-cell malignancies; SSN-510 for the treatment of hematology and solid tumors. The company partnered programs under development include TAK-580 (formerly MLN2480) and Vosaroxin for the treatment of various types of cancer. Sunesis is headquartered in South San Francisco, California, the US.

Sunesis Pharmaceuticals Inc Key Recent Developments

Mar 04,2021: Viracta Therapeutics Strengthens Company Leadership with New Appointments to the Board of Directors and Management Team
Nov 16,2020: Sunesis Pharmaceuticals reports third quarter 2020 financial results and recent highlights
Nov 09,2020: Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent Highlights
Aug 11,2020: Sunesis Pharmaceuticals reports second quarter 2020 financial results and recent highlights
May 07,2020: Sunesis Pharmaceuticals reports first quarter 2020 financial results and recent highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Sunesis Pharmaceuticals Inc – Key Facts
Sunesis Pharmaceuticals Inc – Key Employees
Sunesis Pharmaceuticals Inc – Key Employee Biographies
Sunesis Pharmaceuticals Inc – Major Products and Services
Sunesis Pharmaceuticals Inc – History
Sunesis Pharmaceuticals Inc – Company Statement
Sunesis Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Sunesis Pharmaceuticals Inc – Business Description
Sunesis Pharmaceuticals Inc – Corporate Strategy
Sunesis Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Sunesis Pharmaceuticals Inc – Strengths
Sunesis Pharmaceuticals Inc – Weaknesses
Sunesis Pharmaceuticals Inc – Opportunities
Sunesis Pharmaceuticals Inc – Threats
Sunesis Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sunesis Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 04, 2021: Viracta Therapeutics Strengthens Company Leadership with New Appointments to the Board of Directors and Management Team
Nov 16, 2020: Sunesis Pharmaceuticals reports third quarter 2020 financial results and recent highlights
Nov 09, 2020: Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent Highlights
Aug 11, 2020: Sunesis Pharmaceuticals reports second quarter 2020 financial results and recent highlights
May 07, 2020: Sunesis Pharmaceuticals reports first quarter 2020 financial results and recent highlights
Apr 30, 2020: Sunesis Pharmaceuticals to Host Conference Call on May 7th to Discuss First Quarter 2020 Financial Results and Recent Highlights
Mar 10, 2020: Sunesis Pharmaceuticals reports fourth quarter and full-year 2019 financial results and recent highlights
Mar 03, 2020: Sunesis Pharmaceuticals to Host Conference Call on March 10th to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Recent Highlights
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Sunesis Pharmaceuticals Inc, Key Facts
Sunesis Pharmaceuticals Inc, Key Employees
Sunesis Pharmaceuticals Inc, Key Employee Biographies
Sunesis Pharmaceuticals Inc, Major Products and Services
Sunesis Pharmaceuticals Inc, History
Sunesis Pharmaceuticals Inc, Subsidiaries
Sunesis Pharmaceuticals Inc, Key Competitors
Sunesis Pharmaceuticals Inc, Ratios based on current share price
Sunesis Pharmaceuticals Inc, Annual Ratios
Sunesis Pharmaceuticals Inc, Annual Ratios (Cont...1)
Sunesis Pharmaceuticals Inc, Interim Ratios
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sunesis Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Sunesis Pharmaceuticals Inc (VIRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rad Source Technologies Inc:企業の戦略的SWOT分析
    Rad Source Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Arcturus Therapeutics Ltd (ARCT):製薬・医療:M&Aディール及び事業提携情報
    Summary Arcturus Therapeutics Ltd (Arcturus), formerly Alcobra Ltd is a pharmaceutical company that develops a portfolio of nucleic acid therapeutics for treatment of diseases with unmet medical needs. It discovers and develops RNA medicines and design and utilize lipid-mediated drug delivery system …
  • Bezeq The Israel Telecommunication Corp. Ltd. (BEZQ):企業の財務・戦略的SWOT分析
    Bezeq The Israel Telecommunication Corp. Ltd. (BEZQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • MRF Ltd (MRF):企業の財務・戦略的SWOT分析
    MRF Ltd (MRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Vedanta Resources Plc:企業の戦略・SWOT・財務分析
    Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • T-System Inc-医療機器分野:企業M&A・提携分析
    Summary T-System Inc (T-System) is a healthcare service provider that offers clinical, financial, operational, and regulatory solutions. The company offers documentation solutions, which include EV, an emergency department information system; EV for physicians, a solution with ER-specific clinical c …
  • Daewoong Pharmaceutical Co Ltd (069620):企業の財務・戦略的SWOT分析
    Daewoong Pharmaceutical Co Ltd (069620) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Xenikos BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Xenikos BV (Xenikos) is a drug company that develops immunotherapy medicines. The company develops medicines based on the action of conjugated antibodies to patients suffering from serious immune diseases. Its research and development activities includes transplant related rejection, Graft v …
  • MAN SE (MAN):企業の財務・戦略的SWOT分析
    MAN SE (MAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Bionomics Ltd (BNO):企業の財務・戦略的SWOT分析
    Summary Bionomics Ltd (Bionomics) is a biopharmaceutical company that discovers and develops treatments for cancer, and central nervous system disorders such as anxiety, depression and Alzheimer's disease. The company provides pipeline products such as BNC210, BNC 105, BNC101 and BNC375, among other …
  • Tepha Inc:企業の製品パイプライン分析
    Summary Tepha Inc (Tepha) is a medical device firm that develops and commercializes biomaterial technology products. The firm offers products such as absorbable monofilament suture, absorbable monofilament mesh, composite mesh and absorbable surgical film. It also provides platforms including absorb …
  • Oxford Nanopore Technologies Ltd-医療機器分野:企業M&A・提携分析
    Summary Oxford Nanopore Technologies Ltd (Oxford Nanopore), formerly Oxford NanoLabs Ltd., is a biotechnology diagnostic company. It develops technologies for molecular detection and analysis. The company offers a range of nanopores and devices such as MinION, PromethION and GridION used for the ana …
  • Lyka Labs Ltd (LYKALABS)-製薬・医療分野:企業M&A・提携分析
    Summary Lyka Labs Ltd (Lyka Labs) is a developer and manufacturer of pharmaceutical formulations and active pharmaceutical ingredients. The company offers development of various formulations which include lyophilized injections, differentiated dermatological formulation, dry powder injections, and o …
  • Onxeo SA (ONXEO):企業の財務・戦略的SWOT分析
    Summary Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as livatag, belchop, beleodaq, amep, asidna and validive, among others. It offers drugs for the treatment of …
  • Kracie Holdings, Ltd.:戦略・SWOT・企業財務分析
    Kracie Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kracie Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Kroton Educacional S.A. (KROT3):企業の財務・戦略的SWOT分析
    Kroton Educacional S.A. (KROT3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • The Hachijuni Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Hachijuni Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Hachijuni Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nexeon MedSystems Inc-医療機器分野:企業M&A・提携分析
    Summary Nexeon MedSystems Inc (Nexeon) is a bioelectronics company that develops and commercializes therapies and devices for the treatment of cardiovascular diseases. The company’s products categories include nanotechnology-based devices, embolic protection systems, local drug and biologic delivery …
  • BW Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary BW Group Ltd (BW Group) formerly Bergesen Worldwide Limited, is an oil and gas company which provides maritime services. The company offers oil and gas shipping and others related services. It offers environmental technologies, floating gas infrastructure, and deepwater production services. …
  • Reliance Worldwide Corporation Ltd (RWC):企業の財務・戦略的SWOT分析
    Reliance Worldwide Corporation Ltd (RWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆